Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma

D. Jay McCracken, Emma Celano, Alfredo Voloschin, William L. Read, Jeffrey J. Olson

Journal of Neuro-Oncology · 2016 · 25 citations · 39 references

Concepts

References

39